pipette
ESEspañol

IBDex: A Frozen Patient-Scale Atlas for Bulk Transcriptomics in Inflammatory Bowel Disease

A. K. Madeswaran, A. Acharjee

PreprintReal-world use

In the authors' words

Background and Aims: Bulk mucosal RNA sequencing in inflammatory bowel disease (IBD) is analyzed one cohort at a time, so each study rebuilds its own molecular scale. We aimed to build a frozen atlas that new cohorts could use without retraining. Methods: We built IBDex from 3,168 intestinal biopsies from 1,680 patients with Crohn's disease, ulcerative colitis or no IBD, drawn from four cohorts. Patients were kept within a single training, validation or test partition. A tissue-aware conditional variational autoencoder with adversarial suppression of cohort identity was trained on a 3,000-gene interface. The scaling, encoder, decoder, pathway basis and phenotype directions were then frozen. Phenotype-anchored counterfactual perturbation (PACP) produced anatomy-conditioned gene-response maps. We tested the atlas without parameter updates in three unseen IBD cohorts, a longitudinal olamkicept trial, and cohorts with primary sclerosing cholangitis (PSC) or colorectal cancer (CRC). Results: In held-out data, dataset identity fell to near chance (balanced accuracy 0.307 vs 0.250). Anatomy, diagnosis and inflammation remained recoverable (inflammation AUC 0.82). Marginal differential expression conflated inflammation and disease state (rho = 0.834). PACP separated them (rho = -0.161), with inflammation driven by TNF-NF-kappaB, and disease state by proliferative, type I interferon and metabolic programs. In 93 patients in combined endoscopic and histological remission, inflammation approached controls (AUC 0.58), but disease state stayed displaced (AUC 0.725, P = 1.8 x 10^-10). The frozen atlas recovered clinical, single-cell-defined and disease-behavior structure in unseen cohorts. It also tracked responder trajectories during olamkicept therapy and separated PSC (patient-level AUC 0.794) and CRC (AUC 0.938-1.000). Where de novo differential expression became unreliable, transferred response maps stayed reproducible (rho >= 0.89). Conclusions: IBDex turns historical bulk biopsy data into a reusable reference. It shows that deep remission moves inflammation toward control levels but leaves a persistent molecular disease state.

Main resultThe abstract does not state a limitation.

Appeared: Friday, October 23. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.10.20.26365993